---
figid: PMC6263089__gr4
figtitle: MTOR/S6K intracellular signal transduction pathways in the osteoclast
organisms:
- NA
pmcid: PMC6263089
filename: gr4.jpg
figlink: /pmc/articles/PMC6263089/figure/fig0004/
number: F4
caption: 'Schematic illustration of mTOR/S6K intracellular signal transduction pathways
  in the osteoclast . M-CSF and RANKL are required for osteoclastogenesis and osteoclast
  activation. Upon activation of their respective receptors, M-CSF-R and RANK, downstream
  signaling pathways are activated. Signals converge on the mTOR/S6K axis. Upon mTOR
  inhibition, suppression of this pathway leads to osteoclast apoptosis and thereby
  reduced bone resorption. Abbreviations: Akt, protein kinase B; MAPK, mitogen-activated
  protein kinase; mTOR, mammalian target of rapamycin; P, phosphate; RANK, receptor
  activator of nuclear factor kappa-B; RANKL, receptor activator of nuclear factor
  kappa-B ligand; S6K, 40 S ribosomal S6 kinase; src, steroid receptor coactivator;
  TNF, tumor necrosis factor; TSC tuberous sclerosis complex.'
papertitle: The impact of mammalian target of rapamycin inhibition on bone health
  in postmenopausal women with hormone receptor-positive advanced breast cancer receiving
  everolimus plus exemestane in the phase IIIb 4EVER trial.
reftext: Peyman Hadji, et al. J Bone Oncol. 2019 Feb;14:100199.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9464346
figid_alias: PMC6263089__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6263089__F4
ndex: 6f3c0d31-defd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6263089__gr4.html
  '@type': Dataset
  description: 'Schematic illustration of mTOR/S6K intracellular signal transduction
    pathways in the osteoclast . M-CSF and RANKL are required for osteoclastogenesis
    and osteoclast activation. Upon activation of their respective receptors, M-CSF-R
    and RANK, downstream signaling pathways are activated. Signals converge on the
    mTOR/S6K axis. Upon mTOR inhibition, suppression of this pathway leads to osteoclast
    apoptosis and thereby reduced bone resorption. Abbreviations: Akt, protein kinase
    B; MAPK, mitogen-activated protein kinase; mTOR, mammalian target of rapamycin;
    P, phosphate; RANK, receptor activator of nuclear factor kappa-B; RANKL, receptor
    activator of nuclear factor kappa-B ligand; S6K, 40 S ribosomal S6 kinase; src,
    steroid receptor coactivator; TNF, tumor necrosis factor; TSC tuberous sclerosis
    complex.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CSF1
  - TNF
  - TNFSF11
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CDC42
  - RAC1
  - RNASE1
  - TRAF6
  - TRAF2
  - TANK
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - CUX1
  - SART3
  - SRC
  - FGR
  - FYN
  - YES1
  - AGFG1
  - RIPK1
  - DCAF1
  - RPAIN
  - TSC2
  - TSC1
  - CCL26
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - MAP2K1
  - MAP2K2
  - NEK6
  - NEK7
  - MTOR
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - RPS6KB1
  - EIF4EBP1
  - BAD
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - EIF4E
  - EIF4E2
  - EIF4E3
  - MST1
  - STK4
  - LY294002
  - PD98059
  - Rapamycin
  - Cancer
---
